$CRM

Salesforce Stock’s Dreamforce Test Starts Tomorrow With cRPO Growth at 14%

Salesforce shares rose 2.61% to $254.19. The company's Dreamforce event and investor session will test its AI growth case. Current remaining performance obligation (cRPO) grew 14% to $33.5 billion. Revenue grew 11% to $11.3 billion, including $456 million from Informatica. The company aims for $46.1B-$46.4B in full-year revenue and 14% cRPO growth in Q3.

Original reporting
Published Sep 14, 2026, 2:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 4:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Salesforce Stock’s Dreamforce Test Starts Tomorrow With cRPO Growth at 14% — source image
Decision brief

The 30-second read

$CRMBullishMed
01

Why it matters

The disclosed cRPO and revenue guidance provide a concrete metric for evaluating the sustainability of AI bookings.

02

Market read

Fresh guidance and cRPO data create a short‑term trading opportunity ahead of the analyst day.

03

What to watch

The $25B share‑repurchase program settlement delay and potential macro slowdown could temper upside.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Salesforce is using Dreamforce to showcase AI product adoption and to address investor concerns about acquisition‑driven growth.

Company-level read

Ticker impact

$CRMBullishHigh confidence
Context

Salesforce reported fiscal Q2 cRPO of $33.5B, up 14% YoY, and gave FY revenue guidance of $46.1B‑$46.4B ahead of Dreamforce events.

Expected impact

Potential modest upside if investor session confirms organic growth beyond Informatica acquisition.

Evidence & confidence

Guidance and cRPO numbers are fresh disclosures; traders can position ahead of the analyst day.

Market effects

AI‑focused enterprise software sector may see broader lift as cRPO growth validates demand.

U.S. tech equities could benefit from positive sentiment around AI contracts.

Global investors tracking AI spend may adjust exposure to cloud and SaaS names.

Counterpoint

cRPO growth may be inflated by one‑time Informatica acquisition revenue; organic AI demand could lag.

Key entities

  • Marc Benioff

    Chair and CEO presenting at the investor session.

  • Informatica

    Contributed $456M to quarterly revenue and ~4 percentage points of FY growth.

Related articles

$NOWMed

ServiceNow Climbs 5% as Software Sidesteps AI Selloff; Adobe Gains 4%, Salesforce Ticks Up

ServiceNow (NOW) rose 5% to $139.62, Adobe (ADBE) gained 4% to $261.90, and Salesforce (CRM) increased 3% to $254.82. The gains followed a weekend essay by Anthropic CEO Dario Amodei, which sparked a rotation into enterprise software. Analysts raised ServiceNow's price targets to $155 and $170, citing AI products and growth. The iShares Expanded Tech-Software Sector ETF (IGV) climbed 2%, while the Invesco QQQ Trust (QQQ) dropped 2%.

$CRMMed

Salesforce Introduces New Agentforce AI Agents for Enterprise Work

Salesforce has introduced a new portfolio of AI agents, called Agentforce, designed for enterprise work. These agents are built for specific jobs like customer service, IT/HR, sales, and supply chain, and can work across business functions. The company reports significant adoption, with 7 billion Agentic Work Units delivered. The agents are connected to Customer 360 and can be tailored to individual companies. Early results show agents resolving up to 90% of tasks autonomously. Salesforce also i

$CRMMedAI 8/10

Salesforce Spent a Record $27.1 Billion on Buybacks in One Quarter. Here Is Why That Signal Matters.

Salesforce (CRM) executed a record $27.1 billion in share buybacks in Q1, part of a $50 billion program. The company's stock, depressed by AI concerns, hit a 52-week low of $146 but has since recovered to $246. Q2 earnings beat estimates, with adjusted EPS of $5.90 and revenue of $11.35 billion, driven by gains in its Anthropic stake and strong free cash flow growth.

Med

Computacenter’s salesforce bounces it to an AI high

Computacenter, a UK-based IT services firm, saw its share price reach an all-time high after reporting record half-year operating profits of £153m, driven by AI-related infrastructure demand, particularly in the US. The company, founded in 1979, has a market cap of over £6bn and is listed on the FTSE-100. Management predicts continued growth, though there are concerns about declining margins.